Cell Surface Markers Market Research Report – Global Forecast till 2030

Cell Surface Markers Market Size, Trends and Industry Outlook by Product (Antibody, PCR Array), by Source (Mice, Rat), by Cell Type (T Cells, B Cells, NK Cells), by Application (Research (Stem Cell, Immunology), Clinical (Oncology, Hematology)) - Global Forecast Till 2030

ID: MRFR/HC/5941-HCR | February 2021 | Region: Global | 90 Pages         

Cell Surface Markers Market

Cell Surface Markers Market size is expected to register a CAGR of 8.80 % and was valued at USD 1,415.05 Million.

Segmentation

By Product Antibody Pcr Array
By Source Mice Rat
By Cell Type T Cells B Cells Nk Cells
By Application Research Clinical

Key Players

  • Bio-Rad Laboratories
  • Inc.
  • Abbott
  • Siemens Healthcare Private Limited
  • Beckman Coulter
  • Inc.
  • F. Hoffmann-La Roche Ltd
  • NIHON KOHDEN CORPORATION
  • Thermo Fisher Scientific
  • BD
  • Abcam plc.
  • QIAGEN
  • Danaher
  • GenScript
  • Merk KGaA
  • BioLegend
  • Inc.
  • Cell Signaling Technology
  • Inc.
  • Bio-Techne and Others.

Drivers

  • Ris
  • ing inclination towards minimizing healthcare expenditure
  • Advancement in healthcare technology
Speak to Analyst Request a Free Sample

Cell Surface Markers Market Scenario


Cell surface markers market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD  1,415.05 million in 2017 and is projected to grow at a CAGR of 8.80% over the forecast period. Cell surface markers are protein or antigenic determinants which are found on the surface of specific types of cells. They act as a marker for identifying these specific types of cell. Determining the ligands or drug response in research activities is carried out through cell surface marker analysis.


The factors such as advancement in healthcare technology, rising inclination towards minimizing healthcare expenditure by reducing the diagnosis costs are expected to propel the growth of the market. However, the complex products and expensive instruments & reagents used in cell marker analysis can hamper the market growth over the forecast period.


Cell Surface Markers Market Segmentation


The global cell surface markers market has been segmented into product, source, cell type and applications.


The market, on the basis of product, has been segmented into antibody and PCR array.


The market, by source, has been segmented into mice, rat and others.


The cell surface markers market, by cell type, has been segmented into T cells, B cells and NK cells.


The market, by applications, has been segmented into research, clinical and others. Research segment has been further divided into stem cell and immunology. Clinical segment is further divided into oncology and hematology. Research segment is expected to hold the largest market share owing to wide use in pharmaceutical research. Clinical segment is anticipated to grow at the fastest CAGR owing to rising applications in the segment.


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The cell surface markers market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The cell surface markers market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The market in the Middle East & Africa has been segmented into the Middle East and Africa.


Regional Market Summary


Global Cell Surface Markers Market Share (%), by Region, 2017


Cell Surface Markers Market


Source: Centers for Disease Control and Prevention (CDC), Eurostat, White Papers, Company Presentations, Annual Reports


Geographically, the Americas is anticipated to dominate the global cell surface markers market owing to the significant amount of research and development activities in the region and rising healthcare expenditure. For instance, according to U.S. Centers for Medicare & Medicaid Services, in 2017, healthcare spending in US increased 3.9% to reach USD 3.5 trillion or USD 10,739 per person. Europe is expected to hold the second largest position in the global cell surface markers market. The market growth in this region is attributed to the rising funding for life science research. The cell surface markers market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and the Rest of the Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to the rising number of diagnostic laboratories and government initiative towards research centers. For instance, according to the Australian Institute of Health and Welfare, during 2015 to 2016, the total health expenditure was USD 181 billion. Out of this, USD 69 billion was spent on hospitals, which is a real increase of USD 2 billion from the previous year. During the same years, non-government sources spent USD 55.8 billion on health. The Middle East & Africa are expected to grow at a slow rate owing to a developing healthcare infrastructure.


Global Cell Surface Markers Market, by Product



  • Antibody

  • PCR Array


Global Cell Surface Markers Market, by Source



  • Mice

  • Rat

  • Others


Global Cell Surface Markers Market, by Cell Type



  • T Cells

  • B Cells

  • NK Cells


Global Cell Surface Markers Market, by Applications



  • Research

    • Stem Cell

    • Immunology



  • Clinical

    • Oncology

    • Hematology



  • Others


Global Cell Surface Markers Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • South America



  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe



  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • The Middle East & Africa

    • Middle East

    • Africa




Global Cell Surface Markers Market, by Key Players

  • Bio-Rad Laboratories, Inc.

  • Siemens Healthcare Private Limited

  • Beckman Coulter, Inc.

  • NIHON KOHDEN CORPORATION

  • Hoffmann-La Roche Ltd

  • BD

  • Abcam plc.

  • QIAGEN

  • Thermo Fisher Scientific

  • Abbott

  • Danaher

  • GenScript

  • Merk KGaA

  • BioLegend, Inc.

  • Cell Signaling Technology, Inc.

  • Bio-Techne


Intended Audience



  • Research and Development Organization

  • Biotechnology Companies

  • Healthcare Organizations

  • Academics and Research Institutes

    Geographically, the Americas is anticipated to dominate the global cell surface markers market owing to the significant amount of research and development activities in the region and rising healthcare expenditure. For instance, according to U.S. Centers for Medicare & Medicaid Services, in 2017, healthcare spending in US increased 3.9% to reach USD 3.5 trillion or USD 10,739 per person. Europe is expected to hold the second largest position in the global market. The market growth in this region is attributed to the rising funding for life science research. The cell surface markers market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and the Rest of the Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to the rising number of diagnostic laboratories and government initiative towards research centers. For instance, according to the Australian Institute of Health and Welfare, during 2015 to 2016, the total health expenditure was USD 181 billion. Out of this, USD 69 billion was spent on hospitals, which is a real increase of USD 2 billion from the previous year. During the same years, non-government sources spent USD 55.8 billion on health. The Middle East & Africa are expected to grow at a slow rate owing to a developing healthcare infrastructure.


    Global Cell Surface Markers Market, by Product



    • Antibody

    • PCR Array


    Global Cell Surface Markers Market, by Source



    • Mice

    • Rat

    • Others


    Global Cell Surface Markers Market, by Cell Type



    • T Cells

    • B Cells

    • NK Cells


    Global Cell Surface Markers Market, by Applications



    • Research


      • Stem Cell

      • Immunology


    • Clinical


      • Oncology

      • Hematology


    • Others


    Global Cell Surface Markers Market, by Region



    • Americas


      • North America


        • US

        • Canada


      • South America


    • Europe


      • Western Europe


        • Germany

        • France

        • Italy

        • Spain

        • UK

        • Rest of Western Europe


      • Eastern Europe


    • Asia-Pacific


      • Japan

      • China

      • India

      • Australia

      • South Korea

      • Rest of Asia-Pacific


    • The Middle East & Africa


      • Middle East

      • Africa



    Global Cell Surface Markers Market, by Key Players



    • Bio-Rad Laboratories, Inc.

    • Siemens Healthcare Private Limited

    • Beckman Coulter, Inc.

    • NIHON KOHDEN CORPORATION

    • Hoffmann-La Roche Ltd

    • BD

    • Abcam plc.

    • QIAGEN

    • Thermo Fisher Scientific

    • Abbott

    • Danaher

    • GenScript

    • Merk KGaA

    • BioLegend, Inc.

    • Cell Signaling Technology, Inc.

    • Bio-Techne


    Intended Audience



    • Research and Development Organization

    • Biotechnology Companies

    • Healthcare Organizations

    • Academics and Research Institutes





Report Scope:
Report Attribute/Metric Details
  Market Size   2017 : USD 1415 Million
  CAGR   8.80% (2020 - 2030)
  Base Year   2019
  Forecast Period   2020-2030
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   By Product, Source, Application
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Bio-Rad Laboratories, Inc., Abbott, Siemens Healthcare Private Limited, Beckman Coulter, Inc. , F. Hoffmann-La Roche Ltd, NIHON KOHDEN CORPORATION, Thermo Fisher Scientific, BD, Abcam plc., QIAGEN, Danaher, GenScript, Merk KGaA, BioLegend, Inc., Cell Signaling Technology, Inc., Bio-Techne and Others.
  Key Market Opportunities   Increasing research & development investments by industry players
  Key Market Drivers

  • Rising inclination towards minimizing healthcare expenditure
  • Advancement in healthcare technology


  • Speak to Analyst Ask for Customization